This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Drugsrss

Amgen (AMGN) Stock Falls as Novartis Begins Selling Biosimilar Version of Neupogen

  • Tickers in this article:
  • AMGN

Amgen (AMGN) shares are declining after rival Novartis (NVG) launched a biosimilar version of Amgen's Neupogen.

09/03/15 - 03:03 PM EDT

Acadia Pharmaceuticals (ACAD) Stock Climbs on Drug Application for Parkinson's Treatment

  • Tickers in this article:
  • ACAD

Acadia Pharmaceuticals (ACAD) shares are rising after the company submitted a new drug application for its Parkinson's related psychosis treatment.

09/03/15 - 10:57 AM EDT

Try Jim Cramer's Action Alerts PLUS
Lannett (LCI) Stock Continues to Spike Following $1.23 Billion Generic Drug Maker Deal

Lannett (LCI) Stock Continues to Spike Following $1.23 Billion Generic Drug Maker Deal

  • Tickers in this article:
  • LCI

Lannett (LCI) shares are up over 15% today following the purchase of UCB SA's U.S. generic drug business.

09/03/15 - 10:24 AM EDT

Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor

Biotech Stock Mailbag: Sarepta, Biomarin, Spark, Raptor

Biotech columnist Adam Feuerstein answers readers' questions about health care.

09/03/15 - 06:23 AM EDT

Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study

Sage Psychiatric Drug Shows Activity Hint in Small Muscle Tremor Study

  • Tickers in this article:
  • SAGE

The signal of activity Sage Therapeutics sees with SAGE-547 in essential tremor may turn out to be real or a mirage.

09/03/15 - 06:01 AM EDT

Jim Cramer -- Watch Campbell Soup, Medtronic Earnings

Jim Cramer -- Watch Campbell Soup, Medtronic Earnings

Campbell Soup and Medtronic both report their latest quarterly results on Thursday, and Jim Cramer is watching them closely.

09/02/15 - 12:42 PM EDT

Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant

Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant

  • Tickers in this article:
  • SURG

Synergetics USA (SURG) shares are spiking after the company was acquired by Valeant Pharmaceuticals (VRX) for $166 million today.

09/02/15 - 09:59 AM EDT

Valeant Pharmaceuticals (VRX) Stock Climbs on Synergetics Deal

Valeant Pharmaceuticals (VRX) Stock Climbs on Synergetics Deal

  • Tickers in this article:
  • VRX

Valeant Pharmaceuticals (VRX) shares are rising after the company announced the $166 million purchase of ophthalmic surgical device manufacturer Synergetics (SURG).

09/02/15 - 09:53 AM EDT

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).

09/01/15 - 12:14 PM EDT

New Ratings on American Airlines, Delta and 8 Other Stocks -- Analysts' Actions

New Ratings on American Airlines, Delta and 8 Other Stocks -- Analysts' Actions

Here are Tuesday's top research calls, including upgrades on American Airlines, Delta and Scientific Games.

09/01/15 - 08:58 AM EDT

The Numbers Behind Biotech's Horrible, No Good, Awful August

The Numbers Behind Biotech's Horrible, No Good, Awful August

Among all U.S.-listed biotech stocks, regardless of market cap, only 68 companies managed to end August with higher stock prices, while 267 biotech stocks lost ground.

09/01/15 - 07:27 AM EDT

Mylan (MYL) Stock Continues Climb After Shareholders Approve Perrigo Bid

Mylan (MYL) Stock Continues Climb After Shareholders Approve Perrigo Bid

  • Tickers in this article:
  • MYL

Mylan (MYL) shares are rising after the company's shareholders approved its $31.2 billion bid for Perrigo (PRGO).

08/31/15 - 10:22 AM EDT

Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline

Amicus Acquires Scioderm, Adds Drug for Rare Skin Disorder to Pipeline

  • Tickers in this article:
  • FOLD

Acquiring Scioderm gives Amicus another late-stage orphan disease drug expected to have pivotal trial data in the first half of next year.

08/31/15 - 06:01 AM EDT

Mylan Shareholders Back Proposal to Buy Perrigo

Mylan Shareholders Back Proposal to Buy Perrigo

Shareholders vote in favor of the proposed purchase as Perrigo continues to push back against the unsolicited offer.

08/28/15 - 03:08 PM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

Chart of I:DJI
DOW 16,157.96 -216.80 -1.32%
S&P 500 1,924.57 -26.56 -1.36%
NASDAQ 4,689.0920 -44.4050 -0.94%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs